James I. Ito
About
James I. Ito is a scholar working on Epidemiology, Infectious Diseases and Microbiology.
According to data from OpenAlex, James I. Ito has authored 57 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 33 papers in Infectious Diseases and 15 papers in Microbiology. Recurrent topics in James I. Ito's work include Antifungal resistance and susceptibility (32 papers), Fungal Infections and Studies (26 papers) and Reproductive tract infections research (12 papers). James I. Ito is often cited by papers focused on Antifungal resistance and susceptibility (32 papers), Fungal Infections and Studies (26 papers) and Reproductive tract infections research (12 papers). James I. Ito collaborates with scholars based in United States, Netherlands and Canada. James I. Ito's co-authors include Alison G. Freifeld, John R. Wingard, Michael Boeckh, Craig A. Mullen, Jo‐Anne H. Young, Kenneth V. I. Rolston, Eric J. Bow, Kent A. Sepkowitz, Issam Raad and Joseph M. Lyons and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.
In The Last Decade
James I. Ito
57 papers receiving 5.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| James I. Ito United States | 28 | 2.7k | 2.4k | 2.0k | 1.1k | 593 | 57 | 5.4k | ||
| Jerry L. Shenep United States | 37 | 2.4k 0.9× | 2.1k 0.9× | 1.1k 0.6× | 1.4k 1.2× | 591 1.0× | 109 | 5.8k | ||
| Alison G. Freifeld United States | 37 | 3.7k 1.4× | 3.7k 1.5× | 2.8k 1.4× | 1.6k 1.4× | 766 1.3× | 97 | 7.4k | ||
| Marc Rubin United States | 33 | 2.1k 0.8× | 2.2k 0.9× | 2.6k 1.3× | 737 0.6× | 598 1.0× | 52 | 8.1k | ||
| Lowell S. Young United States | 39 | 2.4k 0.9× | 2.8k 1.2× | 2.0k 1.0× | 1.3k 1.2× | 574 1.0× | 123 | 6.8k | ||
| Thomas Lehrnbecher Germany | 51 | 2.9k 1.1× | 3.5k 1.4× | 3.0k 1.5× | 640 0.6× | 620 1.0× | 264 | 8.2k | ||
| Jo‐Anne H. Young United States | 32 | 3.8k 1.4× | 4.8k 2.0× | 3.9k 1.9× | 1.2k 1.1× | 716 1.2× | 96 | 9.0k | ||
| Małgorzata Mikulska Italy | 41 | 1.8k 0.7× | 2.5k 1.0× | 2.6k 1.3× | 844 0.7× | 263 0.4× | 166 | 5.2k | ||
| Drew J. Winston United States | 48 | 2.5k 0.9× | 5.3k 2.2× | 3.4k 1.7× | 631 0.6× | 416 0.7× | 97 | 8.0k | ||
| Stephen C. Schimpff United States | 36 | 2.7k 1.0× | 1.7k 0.7× | 872 0.4× | 1.4k 1.2× | 335 0.6× | 114 | 5.3k | ||
| K. V. I. Rolston United States | 34 | 1.3k 0.5× | 1.5k 0.6× | 1.0k 0.5× | 631 0.6× | 314 0.5× | 86 | 3.5k |
Countries citing papers authored by James I. Ito
Since
Specialization
Citations
This map shows the geographic impact of James I. Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James I. Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James I. Ito more than expected).
Fields of papers citing papers by James I. Ito
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by James I. Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James I. Ito. The network helps show where James I. Ito may publish in the future.
Co-authorship network of co-authors of James I. Ito
This figure shows the co-authorship network connecting the top 25 collaborators of James I. Ito. A scholar is included among the top collaborators of James I. Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James I. Ito. James I. Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Dadwal, Sanjeet, et al.. (2020). First Case of Invasive Stachybotrys Sinusitis. Clinical Infectious Diseases. 72(8). 1386–1391.
2.
Baddley, John W., David R. Andes, Kieren A. Marr, et al.. (2013). Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis. Medical Mycology. 51(2). 128–135.
3.
Champer, Jackson, Diana Díaz-Arévalo, Teresa Hong, et al.. (2012). Protein targets for broad‐spectrum mycosis vaccines: quantitative proteomic analysis of Aspergillus and Coccidioides and comparisons with other fungal pathogens. Annals of the New York Academy of Sciences. 1273(1). 44–51.
4.
Freifeld, Alison G., Eric J. Bow, Kent A. Sepkowitz, et al.. (2011). Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 52(4). e56–e93.
5.
Lockhart, Shawn R., Naureen Iqbal, Peter G. Pappas, et al.. (2011). Comparison of In Vitro Susceptibility Characteristics of Candida Species from Cases of Invasive Candidiasis in Solid Organ and Stem Cell Transplant Recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006. Journal of Clinical Microbiology. 49(7). 2404–2410.
6.
Ito, James I., et al.. (2010). Approaches to the early treatment of invasive fungal infection. Leukemia & lymphoma. 51(9). 1623–1631.
7.
Dadwal, Sanjeet, Bernard Tegtmeier, Ryotaro Nakamura, et al.. (2010). Nontyphoidal Salmonella infection among recipients of hematopoietic SCT. Bone Marrow Transplantation. 46(6). 880–883.
8.
Baddley, John W., David R. Andes, Kieren A. Marr, et al.. (2010). Factors Associated with Mortality in Transplant Patients with Invasive Aspergillosis. Clinical Infectious Diseases. 50(12). 1559–1567.
9.
Ito, James I., Joseph M. Lyons, Teresa Hong, et al.. (2006). Vaccinations with Recombinant Variants of Aspergillus fumigatus Allergen Asp f 3 Protect Mice against Invasive Aspergillosis. Infection and Immunity. 74(9). 5075–5084.
10.
Lyons, Joseph M., James I. Ito, & Servaas A. Morré. (2006). Efficacy of an Immune Modulator in Experimental Chlamydia trachomatis Infection of the Female Genital Tract. Infectious Diseases in Obstetrics and Gynecology. 2006(1). 61265–61265.
11.
Ouburg, Sander, Jolande A. Land, Joseph M. Lyons, et al.. (2006). Do host genetic traits in the bacterial sensing system play a role in the development of Chlamydia trachomatis-associated tubal pathology in subfertile women?. BMC Infectious Diseases. 6(1). 122–122.
12.
Lyons, Joseph M., James I. Ito, A. S. Peña, & Servaas A. Morré. (2005). Differences in growth characteristics and elementary body associated cytotoxicity between Chlamydia trachomatis oculogenital serovars D and H and Chlamydia muridarum. Journal of Clinical Pathology. 58(4). 397–401.
13.
Chandrasekar, Pranatharthi & James I. Ito. (2005). Amphotericin B Lipid Complex in the Management of Invasive Aspergillosis in Immunocompromised Patients. Clinical Infectious Diseases. 40(Supplement_6). S392–S400.
14.
Ito, James I. & Roya Hooshmand-Rad. (2005). Treatment of Candida Infections with Amphotericin B Lipid Complex. Clinical Infectious Diseases. 40(Supplement_6). S384–S391.
15.
Lyons, Joseph M., et al.. (2005). Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in mice. BMC Infectious Diseases. 5(1). 105–105.
16.
Ito, James I., Pranatharthi Chandrasekar, & Roya Hooshmand-Rad. (2005). Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA). Bone Marrow Transplantation. 36(10). 873–877.
17.
Ito, James I., et al.. (2004). Chlamydia trachomatis serovar E isolates from patients with different clinical manifestations have similar courses of infection in a murine model: host factors as major determinants of C trachomatis mediated pathogenesis. Journal of Clinical Pathology. 57(6). 657–659.
18.
Ito, James I. & Joseph M. Lyons. (2002). Vaccination of Corticosteroid Immunosuppressed Mice against Invasive Pulmonary Aspergillosis. The Journal of Infectious Diseases. 186(6). 869–871.
19.
O’Donnell, Margaret, G. Schmidt, Bernard Tegtmeier, et al.. (1994). Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients.. Journal of Clinical Oncology. 12(4). 827–834.
20.
Denning, David W., et al.. (1992). Antifungal Prophylaxis during Neutropenia or Allogeneic Bone Marrow Transplantation: What is the State of the Art?. Chemotherapy. 38(1). 43–49.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jerry L. Shenep Breakdown of academic impact, for papers by Alison G. Freifeld Breakdown of academic impact, for papers by Marc Rubin Breakdown of academic impact, for papers by Lowell S. Young Breakdown of academic impact, for papers by Thomas Lehrnbecher Breakdown of academic impact, for papers by Jo‐Anne H. Young Breakdown of academic impact, for papers by Małgorzata Mikulska Breakdown of academic impact, for papers by Drew J. Winston Breakdown of academic impact, for papers by Stephen C. Schimpff Breakdown of academic impact, for papers by K. V. I. Rolston